-
2 months ago | 
artforum.com | Richard A. Meyer |Oskar Oprey |Bryan Barcena |Barry Schwabsky
Store and/or access information on a device Cookies, device or similar online identifiers (e.g. login-based identifiers, randomly assigned identifiers, network based identifiers) together with other information (e.g. browser type and information, language, screen size, supported technologies etc.) can be stored or read on your device to recognise it each time it connects to an app or to a website, for one or several of the purposes presented here.
-
Jan 22, 2025 | 
archive.md | Tomoko Otake |Kazuaki Nagata |Richard A. Meyer
Researchers from the Institute of Science Tokyo and Osaka Medical and Pharmaceutical University said that they have developed a peptide that can bind to the spike proteins of SARS-CoV-2 to prevent COVID-19 infections. The peptide, which is a short chain of amino acids, has shown effectiveness in experiments involving various coronavirus strains attempting to infect human cell lines and hamsters.
-
Jan 16, 2025 | 
worldofdtcmarketing.com | Richard A. Meyer
The role of Pharmacy Benefit Managers (PBMs) in the healthcare system has long been debated and scrutinized. Recently, PBMs have been under fire for their opaque pricing practices, which often involve adding significant drug markups. These revelations fuel outrage from patients, healthcare providers, and even policymakers. But the question remains: will anything change? PBMs negotiate drug prices between pharmaceutical companies, insurers, and pharmacies.
-
Jan 15, 2025 | 
worldofdtcmarketing.com | Richard A. Meyer
The effectiveness of pharma TV ads can vary widely depending on factors like the type of drug, the target audience, the messaging strategy, and the regulatory environment. Here are key points to consider regarding their effectiveness:Broad Reach: TV ads reach large, diverse audiences, making them suitable for brand awareness campaigns targeting a wide demographic. Emotional Engagement: Visual storytelling can evoke emotions, building a connection between the audience and the brand.
-
Jan 14, 2025 | 
worldofdtcmarketing.com | Richard A. Meyer
Obtaining insurance coverage for the off-label use of oncology drugs can be challenging due to several factors. Off-label use refers to prescribing a drug for an indication not approved by the FDA. Insurance companies often view these uses as experimental or investigational, which can lead to reimbursement denials.
-
Jan 13, 2025 | 
worldofdtcmarketing.com | Richard A. Meyer
Pharma companies have long been under pressure to create sleek, information-rich product websites. These platforms often serve as the first point of contact for patients and healthcare professionals exploring treatment options. While a functional product website is essential, many pharma marketers fall into the trap of pouring excessive budgets into these digital platforms. Here’s why that approach may not yield the best ROI and why digital agencies might not be the optimal partners for this task.
-
Jan 12, 2025 | 
worldofdtcmarketing.com | Richard A. Meyer
The pharma industry is no stranger to disruption, and 2025 will be a year of significant challenges and transformations. From regulatory pressures to market dynamics, here’s a look at the key obstacles pharma companies face and whether these challenges could lead to more layoffs. Introducing Medicare pricing negotiations in the United States has sent shockwaves through the industry. Blockbuster drugs are being targeted, forcing companies to lower prices, potentially eroding profit margins.
-
Jan 11, 2025 | 
worldofdtcmarketing.com | Richard A. Meyer
The internet has become millions of people’s primary source of health information. Whether researching symptoms, exploring treatment options, or learning about wellness trends, online health seekers rely on digital platforms for answers. Unfortunately, this reliance makes them prime targets for a growing wave of health misinformation. Here’s why this problem is set to escalate—and what can be done about it.
-
Jan 10, 2025 | 
worldofdtcmarketing.com | Richard A. Meyer
Success in direct-to-consumer (DTC) marketing hinges on one critical factor: understanding the audience. Despite the significant budgets allocated to DTC campaigns, many pharma marketers struggle to connect meaningfully with their target market. Why? Often, it’s because they don’t fully grasp their audience’s evolving needs, preferences, and decision-making processes. Patients today are more informed and empowered than ever.
-
Jan 9, 2025 | 
worldofdtcmarketing.com | Richard A. Meyer
Trust is the cornerstone of any effective communication strategy, particularly in the pharmaceutical industry. Patients, caregivers, and healthcare professionals have relied on online content for years to make critical decisions about medications and treatments. However, with the internet awash in unreliable information, the credibility of online health resources is more vital than ever. One actionable step pharma companies can take is integrating a fact-checked logo on their website content.
